Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer

NCT01440413 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT01440413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01440413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2011
Completion date
December 31, 2020
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer